The weekly litigation news digest is live. Subscribe now

Pharmaceutical Anti-Tnf-Alpha Antibody Formulation

Patent No. EP3212667 (titled "Pharmaceutical Anti-Tnf-Alpha Antibody Formulation") was filed by Richter Gedeon Nyrt on Oct 28, 2015. The application was issued on Sep 19, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SAMSUNG BIOEPISDec 12, 2019PATENT BOUTIQUE
BIOGENJun 19, 2019PATENT BOUTIQUE
SAMSUNG BIOEPISJun 19, 2019PATENT BOUTIQUE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3212667

RICHTER GEDEON NYRT
Application Number
EP15808356A
Filing Date
Oct 28, 2015
Status
Revoked
Apr 4, 2025
Publication Date
Sep 19, 2018
External Links
Slate, Register, Google Patents